Kernig’s Sign (Meningitis)
What is Kernig’s Sign (Meningitis)?
Kernig’s sign is a clinical maneuver used by health‑care providers to assess for irritation of the meninges – the protective membranes surrounding the brain and spinal cord. When a patient lies flat on their back, the hip is flexed to 90 degrees, and then the knee is slowly extended, pain or resistance to straightening the leg suggests a positive Kernig’s sign. The finding is most often associated with meningitis, but it can also appear in other conditions that cause meningeal inflammation or irritation.
The sign was first described in 1882 by Russian physician Nikolai Kernig. Although it is not 100 % specific for meningitis, its presence raises suspicion and prompts further evaluation, especially when combined with other classic signs such as Brudzinski’s neck flexion response.
Common Causes
A positive Kernig’s sign can be seen in a variety of infectious, inflammatory, and traumatic conditions that affect the meninges. The most frequent causes include:
- Acute bacterial meningitis – Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, Listeria monocytogenes. Reference: CDC, “Meningitis – Bacterial,” 2024.
- Viral (aseptic) meningitis – Enteroviruses, herpes simplex virus, West Nile virus. Reference: NIH, “Viral Meningitis,” 2023.
- Fungal meningitis – Cryptococcus neoformans (especially in immunocompromised hosts). Reference: WHO, “Fungal Meningitis,” 2022.
- Tuberculous meningitis – Mycobacterium tuberculosis infection of the meninges. Reference: CDC, “Tuberculosis and the Central Nervous System,” 2023.
- Non‑infectious meningeal irritation – Subarachnoid hemorrhage, intracranial hemorrhage, or malignant infiltration (leptomeningeal carcinomatosis).
- Autoimmune disorders – Systemic lupus erythematosus (SLE) or other vasculitides that cause meningitis.
- Post‑lumbar puncture headache – Irritation from cerebrospinal fluid (CSF) leakage.
- Spinal or epidural abscess – Can irritate the dura mater and produce a positive sign.
- Traumatic brain injury – Direct meningeal irritation from skull fractures or penetrating wounds.
Associated Symptoms
When Kernig’s sign is positive, patients often experience additional signs that reflect meningeal inflammation or the underlying disease process. Commonly reported symptoms are:
- Severe headache that is often described as “worst ever.”
- Neck stiffness (nuchal rigidity) and pain on passive neck flexion.
- Fever, chills, and sweats.
- Photophobia (sensitivity to light) and phonophobia (sound sensitivity).
- Nausea, vomiting, and loss of appetite.
- Altered mental status – confusion, lethargy, or reduced consciousness.
- Seizures (especially in bacterial meningitis).
- Skin rash – petechial or purpuric rash suggests meningococcal infection.
- Joint or muscle aches (arthralgia/myalgia) often seen with viral meningitis.
When to See a Doctor
Because meningitis can progress rapidly to life‑threatening complications, early medical evaluation is crucial. Seek care promptly if you notice:
- Sudden, severe headache combined with fever or neck stiffness.
- New onset of confusion, drowsiness, or difficulty waking.
- A rash that does not fade when pressed (suggesting meningococcemia).
- Vomiting that does not improve with fluids, especially if it is repeated.
- Seizures or loss of consciousness.
- Any sign of a positive Kernig’s or Brudzinski’s maneuver, particularly in a child or infant.
- Recent head trauma, recent neurosurgical procedure, or lumbar puncture with worsening symptoms.
Diagnosis
Diagnosing meningitis (and confirming whether a positive Kernig’s sign reflects true meningeal irritation) involves a stepwise approach:
1. Clinical Assessment
- Detailed history – recent infections, travel, immunizations, exposure to sick contacts, immunosuppression.
- Physical exam – assessment of Kernig’s sign, Brudzinski’s sign, cranial nerve function, and focal neurologic deficits.
2. Laboratory Tests
- Blood cultures – to identify bacteremia.
- Complete blood count (CBC) – leukocytosis may support infection.
- C‑reactive protein (CRP) & Erythrocyte sedimentation rate (ESR) – markers of inflammation.
- Serologic tests for specific viruses (enterovirus PCR, HSV PCR, HIV).
3. Imaging
- CT head (non‑contrast) – performed before lumbar puncture if increased intracranial pressure, focal deficits, or seizures are present.
- MRI – more sensitive for early meningitis, subarachnoid hemorrhage, or abscess.
4. Lumbar Puncture (LP)
The cornerstone of diagnosis. Cerebrospinal fluid (CSF) analysis provides:
- Opening pressure – often elevated in bacterial meningitis.
- Cell count & differential – neutrophilic predominance in bacterial disease; lymphocytic in viral/fungal.
- Glucose – low (<40 mg/dL) in bacterial or fungal meningitis.
- Protein – elevated in most forms of meningitis.
- Gram stain & culture – definitive identification of bacterial pathogens.
- Polymerase chain reaction (PCR) – rapid detection of viral or atypical organisms.
5. Additional Tests (if indicated)
- Serum cryptococcal antigen (for suspected fungal meningitis).
- Quantiferon‑TB Gold or tuberculin skin test (TB meningitis).
- Autoimmune panels for SLE/vasculitis.
Treatment Options
Management depends on the underlying cause, but early empiric therapy is essential because delays increase morbidity and mortality.
1. Empiric Antibiotic Therapy (Bacterial Meningitis)
- Adults – Ceftriaxone + vancomycin ± ampicillin (for Listeria coverage in >50 y or immunocompromised).
- Children – Cefotaxime + vancomycin ± ampicillin.
- Duration: usually 10–14 days, longer for certain organisms (e.g., Listeria 14‑21 days).
2. Antiviral Therapy (Viral Meningitis)
- Acyclovir for HSV or varicella‑zoster virus.
- Supportive care for most enteroviral meningitis (no specific antiviral).
3. Antifungal Therapy (Fungal Meningitis)
- Induction with amphotericin B + flucytosine, followed by fluconazole consolidation.
4. Antitubercular Therapy (TB Meningitis)
- Standard 4‑drug regimen (isoniazid, rifampin, pyrazinamide, ethambutol) for 2 months, then continuation phase for 7–10 months.
- Corticosteroids (dexamethasone) are recommended to reduce inflammation and neurological sequelae.
5. Adjunctive Therapies
- Corticosteroids – Dexamethasone given before or with the first dose of antibiotics improves outcomes in bacterial meningitis, especially pneumococcal disease.
- Fluid & electrolyte management – maintain euvolemia; monitor for hyponatremia.
- Seizure prophylaxis – levetiracetam may be used in patients with seizures or high risk.
- Pain control – acetaminophen or NSAIDs as needed, avoiding excessive sedation.
6. Home Care & Supportive Measures
- Rest in a quiet, dimly lit environment.
- Hydration with oral fluids or, if unable, intravenous fluids under medical supervision.
- Fever control with acetaminophen.
- Monitor for worsening symptoms and keep a symptom diary to share with the health‑care team.
Prevention Tips
Many cases of meningitis are preventable through vaccination, hygiene, and safe practices.
- Vaccination – Stay up‑to‑date with:
- MenACWY (meningococcal A, C, W, Y) and MenB (meningococcal B) vaccines.
- PCV13/PPV23 (pneumococcal) vaccines.
- Haemophilus influenzae type b (Hib) vaccine.
- MMR (measles‑mumps‑rubella) and Varicella, which reduce viral meningitis risk.
- Hand hygiene – Frequent hand washing reduces spread of respiratory viruses and bacteria.
- Avoid sharing personal items – Cups, utensils, or nasal sprays can transmit meningococcal bacteria.
- Prompt treatment of ear, sinus, or respiratory infections – Reduces the chance of bacteria entering the bloodstream and meninges.
- Safe injection practices – Use sterile techniques for any invasive procedures.
- Travel precautions – Consider meningococcal vaccination before travel to the “meningitis belt” in Sub‑Saharan Africa.
- Manage chronic conditions – Good control of diabetes, HIV, or immunosuppressive therapy lowers infection risk.
Emergency Warning Signs
If any of the following appear, call emergency services (911 in the U.S.) or go to the nearest emergency department immediately:
- Rapidly worsening headache or neck stiffness.
- New onset confusion, seizures, or loss of consciousness.
- High fever (≥ 39 °C / 102 °F) that does not respond to antipyretics.
- Petechial or purpuric rash, especially on the trunk or limbs.
- Vomiting more than two times in an hour, especially with inability to keep fluids down.
- Sudden weakness or numbness in any limb or face.
- Difficulty breathing or rapid breathing (tachypnea).
Early recognition and treatment of meningitis dramatically improve outcomes. While Kernig’s sign alone is not diagnostic, it remains a valuable bedside clue that should prompt urgent evaluation.
References:
- Centers for Disease Control and Prevention (CDC). “Meningitis – Bacterial.” Updated 2024.
- National Institutes of Health (NIH). “Viral Meningitis.” 2023.
- World Health Organization (WHO). “Fungal Meningitis.” 2022.
- Mayo Clinic. “Meningitis.” Accessed May 2026.
- Cleveland Clinic. “Kernig Sign and Other Meningeal Signs.” 2023.
- American Academy of Pediatrics. “Red Book: 2024‑2025 Report of the Committee on Infectious Diseases.”